Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 3/20 | 0.45 |
| ▸ | DYRK1B | Q9Y463 | 3/20 | 0.45 |
| ▸ | CLK1 | P49759 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 5/20 | 0.38 |
| ▸ | MAOA | P21397 | 10/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10186549 | 1.00 | DYRK1A (0.45) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA | |
| SCHEMBL662263 | 1.00 | DYRK1A (0.45) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA | |
| SCHEMBL12676122 | 1.00 | DYRK1A (0.45) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA | |
| SCHEMBL12675741 | 0.85 | PPARG (0.45) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA | |
| SCHEMBL664822 | 0.85 | PPARG (0.45) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA | |
| SCHEMBL9709390 | 0.85 | PPARG (0.45) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA | |
| SCHEMBL20220599 | 0.82 | DYRK1A (0.44) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA | |
| SCHEMBL5936319 | 0.82 | PRKCA (0.44) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA | |
| SCHEMBL21895492 | 0.82 | PRKCA (0.44) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA | |
| SCHEMBL663296 | 0.82 | PRKCA (0.44) | DYRK1ADYRK1BCLK1SMN1; SMN2PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230018245-A1 | Skin Whitening Composition Containing Dihydro-5-Methylfuran-2(3h)-One Derivative | EPI BIOTECH CO., LTD. (KR) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230018245-A1 | Skin Whitening Composition Containing Dihydro-5-Methylfuran-2(3h)-One Derivative | MC1R, MC5R, MITF | DYRK1A 1465/4885DYRK1B 1376/4885CLK1 2260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.